We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$402M
AUM Growth
-$90.4M
Cap. Flow
-$75.3M
Cap. Flow %
-18.72%
Top 10 Hldgs %
43.57%
Holding
105
New
16
Increased
19
Reduced
23
Closed
32

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$14.1M
2
CRIS icon
Curis
CRIS
+$11.5M
3
MRK icon
Merck
MRK
+$9.64M
4
ICLR icon
Icon
ICLR
+$9.33M
5
GSK icon
GSK
GSK
+$9.19M

Sector Composition

Rank Sector Weight
1 Healthcare 78.82%
2 Consumer Staples 2.03%
3 Technology 0.88%
4 Industrials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIOX
101
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-460,248
Closed -$1.2M
NTUS
102
DELISTED
Natus Medical Inc
NTUS
-169,454
Closed -$4.34M
TRIL
103
DELISTED
Trillium Therapeutics Inc.
TRIL
-15,500
Closed -$166K
CNST
104
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
-166,186
Closed -$3.89M
DFHTU
105
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
-50,000
Closed -$655K

Similar funds

Sio Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sio Capital Management held 105 positions worth $402M, down 18% from $493M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sio Capital Management withdrew a net $75.3M in Q2 2021, closing 32 positions and reducing 23 holdings. Its most notable exit was Merck, an estimated $9.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 87% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Sio Capital Management opened a new position in Aveanna Healthcare worth $14.9M.

  • Sio Capital Management's largest Q2 2021 buy was Aveanna Healthcare: 1,201,607 shares worth $14.9M.
  • Sio Capital Management added most to NeuBase Therapeutics, Inc. Common Stock in Q2 2021, an estimated $2.62M increase.
  • Sio Capital Management's biggest Q2 2021 reduction was Cardinal Health, cutting an estimated $14.1M.
  • Sio Capital Management fully exited Merck in Q2 2021, selling an estimated $9.64M.
  • Sio Capital Management's ten largest holdings make up 44% of its $402M portfolio in Q2 2021.
  • Sio Capital Management opened 16 new positions and closed 32 in Q2 2021.
  • Sio Capital Management's portfolio value fell 18% quarter-over-quarter to $402M.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.